Join Axol Bioscience, King’s College London, and Optics11 Life for a collaborative webinar exploring how to bridge the gap between traditional 2D cardiomyocyte models and more predictive 3D functional assays.
Date: 16 July 2026 | Time: 16:00 CET
We will begin with an overview from Axol Bioscience of axoCellsTM human iPSC-derived cardiomyocytes, highlighting their robust characterization, enhanced maturation, reproducibility, and suitability for pharmacological and functional assays. Through representative datasets demonstrating consistent and predictive drug responses, we will illustrate their value as a scalable and reliable foundation for cardiac research and discuss key considerations when advancing from 2D systems to more physiologically relevant 3D models.
Optics11 Life will then introduce the Cuore platform, demonstrating how it enables high-resolution measurement of contractile function in engineered cardiac tissues and supports more physiologically relevant, translational readouts.
Finally, researchers from King’s College London will present a case study showcasing their work using Axol cells, including how their research expands toward advanced applications in 3D tissue models.
The session will conclude with an interactive Q&A discussion.
Who should attend:
Researchers in cardiac biology, drug discovery, safety pharmacology, and tissue engineering interested in improving the predictive power of in vitro cardiac models.
Speakers
Jamie Bhagwan
Scientific Group Leader
Axol Bioscience
Tom Berkers
Product Manager Cuore
Optics11 Life
Katarzyna Kmiotek-caller
Research Associate
King’s College London
